Article · 29 Aug 2026
Conference abstract
Evaluation of the efficacy, safety and immunity of chitosan-based oral fowl typhoid vaccine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
S almonella enterica serovar Gallinarum (S. Gallinarum) is the causative agent of fowl typhoid (FT). S. Gallinarum (SG) resides in the gastrointestinal tract after oral contamination and results in 80% mortality of susceptible birds. Fowl typhoid has been eradicated in developed countries by stringent biosecurity measures and vaccines but is still of considerable importance in many developing countries. The local live attenuated FT vaccine produced by National Veterinary Research Institute (NVRI), Jos, Nigeria is given subcutaneously which is cumbersome in the vaccination of large numbers of chickens. Oral delivery of the local FT vaccine has not yet been fully exploited. Oral FT vaccine would also be beneficial to rural farmers in developing countries like Nigeria who cannot access veterinarians easily. Therefore, a safe and efficient oral delivery system is needed. In this research, we are developing a thermostable oral fowl typhoid vaccine encapsulated in alginate-coated chitosan nanoparticles. Chitosan is a natural cationic polysaccharide that has the ability to enhance the immunogenicity of antigens. It is non-toxic, biodegradable and mucoadhesive. However, chitosan is hydrophilic and is easily soluble in acidic solutions, hence, the coating with an acid-resistant polymer such as anionic alginate sodium onto the surface of chitosan nanoparticles. Alginate-coated chitosan nanoparticles protects vaccines better from degradation in acidic solution (pH 1.5) than the chitosan nanoparticles alone. From various in-vitro stability studies done in the past, alginate-coated chitosan nanoparticles conferred thermostability on the associated antigen. Formulation, characterization and thermostability of the coated chitosan nanoparticles would be performed. Immunogenicity and safety studies of the formulated oral alginate-coated chitosan FT vaccine would be compared to the parenteral commercial FT vaccine PDF HTML
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Onuigbo Ebele”
- BylineArticles whose byline prints “Attama Anthony”
- BylineArticles whose byline prints “Chah Kennedy”
- BylineArticles whose byline prints “Gyang Moses”
- BylineArticles whose byline prints “Okore Vincent”